Growth Metrics

Organon (OGN) Cash from Financing Activities (2020 - 2025)

Historic Cash from Financing Activities for Organon (OGN) over the last 6 years, with Q3 2025 value amounting to -$76.0 million.

  • Organon's Cash from Financing Activities rose 256.41% to -$76.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$456.0 million, marking a year-over-year decrease of 2561.98%. This contributed to the annual value of -$368.0 million for FY2024, which is 3532.51% up from last year.
  • According to the latest figures from Q3 2025, Organon's Cash from Financing Activities is -$76.0 million, which was up 256.41% from -$223.0 million recorded in Q2 2025.
  • In the past 5 years, Organon's Cash from Financing Activities registered a high of $345.0 million during Q2 2021, and its lowest value of -$1.1 billion during Q1 2021.
  • Moreover, its 5-year median value for Cash from Financing Activities was -$82.0 million (2022), whereas its average is -$143.2 million.
  • Its Cash from Financing Activities has fluctuated over the past 5 years, first skyrocketed by 15029.15% in 2021, then plummeted by 32777.78% in 2022.
  • Organon's Cash from Financing Activities (Quarter) stood at -$187.0 million in 2021, then soared by 56.15% to -$82.0 million in 2022, then grew by 6.1% to -$77.0 million in 2023, then decreased by 6.49% to -$82.0 million in 2024, then increased by 7.32% to -$76.0 million in 2025.
  • Its Cash from Financing Activities stands at -$76.0 million for Q3 2025, versus -$223.0 million for Q2 2025 and -$75.0 million for Q1 2025.